Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.79 USD | +0.62% |
|
-2.49% | +9.26% |
Jun. 12 | Transcript : GCM Grosvenor Inc. Presents at Morgan Stanley US Financials, Payments & CRE Conference 2024, Jun-12-2024 01:45 PM | |
May. 21 | GCM Grosvenor Invests in Healthcare Investment Firm | MT |
Strengths
- Growth is a substantial asset for the company, as anticipated by dedicated analysts. Within the next three years, growth is estimated to reach -100% by 2026.
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- This company will be of major interest to investors in search of a high dividend stock.
- Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- The opinion of analysts covering the stock has improved over the past four months.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
Weaknesses
- The company sustains low margins.
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 46.62 times its estimated earnings per share for the ongoing year.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Investment Management & Fund Operators
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+9.26% | 433M | C+ | ||
+2.94% | 8.6B | B+ | ||
-22.83% | 3.73B | B | ||
+11.35% | 3.42B | C- | ||
+41.97% | 2.97B | C | ||
+35.01% | 2.06B | - | - | |
+32.44% | 1.75B | B+ | ||
+39.61% | 1.72B | B- | ||
+14.19% | 1.51B | B | ||
-6.84% | 981M | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- GCMG Stock
- Ratings GCM Grosvenor Inc.